Posted: 17 March 2026 The University of Melbourne has led an Australian consortium that has been awarded $2.1 million in…
READ MOREPosted: 17 March 2026 Dimerix Limited has announced that the ACTION3 Phase 3 clinical trial of DMX-200 has achieved a…
READ MOREPosted: 17 March 2026 MTPConnect has announced the seven Victorian medtech companies selected to participate in the 2026 Pathway to…
READ MORE